Drug Shortage Report for VASOPRESSIN INJECTION USP
Report ID | 15469 |
Drug Identification Number | 02247938 |
Brand name | VASOPRESSIN INJECTION USP |
Common or Proper name | VASOPRESSIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VASOPRESSIN |
Strength(s) | 20UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 5ML VIAL |
ATC code | H01BA |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-07-11 |
Actual start date | |
Estimated end date | 2017-07-31 |
Actual end date | 2017-07-28 |
Shortage status | Resolved |
Updated date | 2017-08-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-08-02 | French | Compare |
v4 | 2017-08-02 | English | Compare |
v3 | 2017-07-12 | English | Compare |
v2 | 2017-07-11 | French | Compare |
v1 | 2017-07-11 | English | Compare |
Showing 1 to 5 of 5